Rachel Bijou, M.D.
Internal Medicine, Advanced Heart Failure and Transplant Cardiology (M.D.) in New York, New York, trained at State University of New York Downstate Medical Center (class of 1988). Their prescriptions cost Medicare Part D more than their services did: $500,582 for 1,089 claims, against $38,127 paid for services in 2024. Novartis Pharmaceuticals Corporation was the largest of 10 companies reporting payments in 2025, $1,418 in all, mostly food and beverage.
Overview
| NPI | 1225115082 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Nov 1, 2006 |
| Last updated in NPPES | Apr 3, 2024 |
| Certified by provider | Apr 3, 2024 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Advanced Heart Failure and Transplant Cardiology Primary | 207RA0001X | 180511 | NY |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | 25MA11438800 | NJ |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | 180511 | NY |
| Internal Medicine, Advanced Heart Failure and Transplant Cardiology | 207RA0001X | 25MA11438800 | NJ |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Advanced Heart Failure and Transplant Cardiology (NJ); Practitioner - Advanced Heart Failure and Transplant Cardiology (NY) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 171 |
|---|---|
| Services billed | 409 across 18 procedure codes |
| Paid by Medicare | $38,127 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,089 · 2,460 30-day fills |
|---|---|
| Patients | 114 |
| Total drug cost | $500,582 |
| Generic share | 74% of claims |
Education and affiliations
| Medical school | State University of New York Downstate Medical Center |
|---|---|
| Graduation year | 1988 |
| Medicare specialty | Advanced Heart Failure And Transplant Cardiology |
| Secondary specialties | Internal Medicine |
| Telehealth | Offers telehealth |
Medical group
- Trustees of Columbia University in the City of New YorkNew York, NY · 2,296 clinicians
Hospital affiliation
- New York-Presbyterian HospitalNew York, NY
Industry payments (Open Payments)
- 2025$1,418 · 62 payments from 10 companies
- 2024$1,115 · 40 payments from 9 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novartis Pharmaceuticals Corporation | $364.61 | 24 |
| Alnylam Pharmaceuticals Inc. | $339.04 | 8 |
| Abbott Laboratories | $207.73 | 3 |
| Astrazeneca Pharmaceuticals LP | $146.11 | 7 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $136.34 | 11 |
What the 2025 payments were for
- Food and Beverage$1,418 · 62 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in New York
- 1124333182
- 1568717692
- 1740561133
- 1841459997
- 1053706325
- 1063918456
- 1356604607
- 1376905380
- 1649563073
- 1336226810
- 1528188190
- 1073994208
All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in New York →